nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—AGPS—acquired immunodeficiency syndrome	0.0449	0.847	CbGpPWpGaD
Icosapent ethyl—DGAT1—skin of body—acquired immunodeficiency syndrome	0.0286	0.147	CbGeAlD
Icosapent ethyl—DGAT1—digestive system—acquired immunodeficiency syndrome	0.0228	0.117	CbGeAlD
Icosapent ethyl—DGAT1—blood—acquired immunodeficiency syndrome	0.0218	0.112	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—acquired immunodeficiency syndrome	0.0211	0.108	CbGeAlD
Icosapent ethyl—DGAT1—vagina—acquired immunodeficiency syndrome	0.0202	0.104	CbGeAlD
Icosapent ethyl—DGAT1—lung—acquired immunodeficiency syndrome	0.0191	0.098	CbGeAlD
Icosapent ethyl—DGAT1—nervous system—acquired immunodeficiency syndrome	0.0177	0.0907	CbGeAlD
Icosapent ethyl—DGAT1—central nervous system—acquired immunodeficiency syndrome	0.017	0.0874	CbGeAlD
Icosapent ethyl—DGAT1—brain—acquired immunodeficiency syndrome	0.0135	0.0694	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—acquired immunodeficiency syndrome	0.013	0.067	CbGeAlD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00357	0.0673	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00187	0.0353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00159	0.03	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000821	0.00109	CcSEcCtD
Icosapent ethyl—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000818	0.00109	CcSEcCtD
Icosapent ethyl—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000818	0.00109	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000817	0.00109	CcSEcCtD
Icosapent ethyl—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000816	0.00109	CcSEcCtD
Icosapent ethyl—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000815	0.00108	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000813	0.00108	CcSEcCtD
Icosapent ethyl—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000811	0.00108	CcSEcCtD
Icosapent ethyl—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000809	0.00108	CcSEcCtD
Icosapent ethyl—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000807	0.00107	CcSEcCtD
Icosapent ethyl—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000805	0.00107	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000802	0.00107	CcSEcCtD
Icosapent ethyl—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.00106	CcSEcCtD
Icosapent ethyl—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000799	0.00106	CcSEcCtD
Icosapent ethyl—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000799	0.00106	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000799	0.00106	CcSEcCtD
Icosapent ethyl—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000798	0.00106	CcSEcCtD
Icosapent ethyl—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000798	0.00106	CcSEcCtD
Icosapent ethyl—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000795	0.00106	CcSEcCtD
Icosapent ethyl—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000794	0.00105	CcSEcCtD
Icosapent ethyl—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000793	0.00105	CcSEcCtD
Icosapent ethyl—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000791	0.00105	CcSEcCtD
Icosapent ethyl—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000787	0.00105	CcSEcCtD
Icosapent ethyl—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000787	0.00105	CcSEcCtD
Icosapent ethyl—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000787	0.00105	CcSEcCtD
Icosapent ethyl—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000787	0.00105	CcSEcCtD
Icosapent ethyl—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000787	0.00105	CcSEcCtD
Icosapent ethyl—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000786	0.00105	CcSEcCtD
Icosapent ethyl—Shock—Indinavir—acquired immunodeficiency syndrome	0.000786	0.00104	CcSEcCtD
Icosapent ethyl—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000783	0.00104	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000782	0.00104	CcSEcCtD
Icosapent ethyl—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000781	0.00104	CcSEcCtD
Icosapent ethyl—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000778	0.00103	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000777	0.00103	CcSEcCtD
Icosapent ethyl—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000777	0.00103	CcSEcCtD
Icosapent ethyl—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000774	0.00103	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000772	0.00103	CcSEcCtD
Icosapent ethyl—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000772	0.00103	CcSEcCtD
Icosapent ethyl—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.00102	CcSEcCtD
Icosapent ethyl—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00077	0.00102	CcSEcCtD
Icosapent ethyl—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000769	0.00102	CcSEcCtD
Icosapent ethyl—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000766	0.00102	CcSEcCtD
Icosapent ethyl—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000764	0.00102	CcSEcCtD
Icosapent ethyl—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000762	0.00101	CcSEcCtD
Icosapent ethyl—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000762	0.00101	CcSEcCtD
Icosapent ethyl—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000761	0.00101	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000759	0.00101	CcSEcCtD
Icosapent ethyl—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000756	0.001	CcSEcCtD
Icosapent ethyl—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000753	0.001	CcSEcCtD
Icosapent ethyl—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000753	0.001	CcSEcCtD
Icosapent ethyl—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000753	0.001	CcSEcCtD
Icosapent ethyl—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000751	0.000998	CcSEcCtD
Icosapent ethyl—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000746	0.000992	CcSEcCtD
Icosapent ethyl—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000744	0.000989	CcSEcCtD
Icosapent ethyl—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000742	0.000987	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000741	0.000985	CcSEcCtD
Icosapent ethyl—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.00098	CcSEcCtD
Icosapent ethyl—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000736	0.000979	CcSEcCtD
Icosapent ethyl—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000736	0.000979	CcSEcCtD
Icosapent ethyl—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000735	0.000978	CcSEcCtD
Icosapent ethyl—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000735	0.000977	CcSEcCtD
Icosapent ethyl—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000734	0.000976	CcSEcCtD
Icosapent ethyl—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000734	0.000976	CcSEcCtD
Icosapent ethyl—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000734	0.000976	CcSEcCtD
Icosapent ethyl—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000734	0.000975	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000731	0.0138	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00073	0.000971	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000729	0.000969	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000728	0.000967	CcSEcCtD
Icosapent ethyl—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000726	0.000966	CcSEcCtD
Icosapent ethyl—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000724	0.000962	CcSEcCtD
Icosapent ethyl—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000723	0.000962	CcSEcCtD
Icosapent ethyl—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000722	0.00096	CcSEcCtD
Icosapent ethyl—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000722	0.00096	CcSEcCtD
Icosapent ethyl—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000719	0.000956	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000719	0.000956	CcSEcCtD
Icosapent ethyl—Rash—Didanosine—acquired immunodeficiency syndrome	0.000717	0.000954	CcSEcCtD
Icosapent ethyl—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.000953	CcSEcCtD
Icosapent ethyl—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000717	0.000953	CcSEcCtD
Icosapent ethyl—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000714	0.000949	CcSEcCtD
Icosapent ethyl—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000712	0.000946	CcSEcCtD
Icosapent ethyl—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000711	0.000945	CcSEcCtD
Icosapent ethyl—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00071	0.000944	CcSEcCtD
Icosapent ethyl—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00071	0.000944	CcSEcCtD
Icosapent ethyl—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000709	0.000942	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000708	0.00094	CcSEcCtD
Icosapent ethyl—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000707	0.00094	CcSEcCtD
Icosapent ethyl—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000706	0.000939	CcSEcCtD
Icosapent ethyl—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000706	0.000938	CcSEcCtD
Icosapent ethyl—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000705	0.000936	CcSEcCtD
Icosapent ethyl—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000703	0.000934	CcSEcCtD
Icosapent ethyl—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000701	0.000932	CcSEcCtD
Icosapent ethyl—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000699	0.000929	CcSEcCtD
Icosapent ethyl—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000698	0.000928	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000698	0.000928	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000697	0.000926	CcSEcCtD
Icosapent ethyl—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000696	0.000926	CcSEcCtD
Icosapent ethyl—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000696	0.000926	CcSEcCtD
Icosapent ethyl—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000696	0.000926	CcSEcCtD
Icosapent ethyl—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000694	0.000923	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000692	0.00092	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000689	0.000916	CcSEcCtD
Icosapent ethyl—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000689	0.000915	CcSEcCtD
Icosapent ethyl—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000688	0.000915	CcSEcCtD
Icosapent ethyl—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000688	0.000915	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000687	0.000914	CcSEcCtD
Icosapent ethyl—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000687	0.000913	CcSEcCtD
Icosapent ethyl—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000683	0.000908	CcSEcCtD
Icosapent ethyl—Pain—Indinavir—acquired immunodeficiency syndrome	0.000683	0.000908	CcSEcCtD
Icosapent ethyl—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000682	0.000907	CcSEcCtD
Icosapent ethyl—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.000905	CcSEcCtD
Icosapent ethyl—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00068	0.000903	CcSEcCtD
Icosapent ethyl—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000679	0.000902	CcSEcCtD
Icosapent ethyl—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000677	0.0009	CcSEcCtD
Icosapent ethyl—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000675	0.000897	CcSEcCtD
Icosapent ethyl—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000674	0.000895	CcSEcCtD
Icosapent ethyl—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000673	0.000894	CcSEcCtD
Icosapent ethyl—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00067	0.000891	CcSEcCtD
Icosapent ethyl—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00067	0.000891	CcSEcCtD
Icosapent ethyl—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00067	0.000891	CcSEcCtD
Icosapent ethyl—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000668	0.000887	CcSEcCtD
Icosapent ethyl—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000664	0.000883	CcSEcCtD
Icosapent ethyl—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000662	0.00088	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00066	0.000877	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000658	0.000875	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000658	0.000874	CcSEcCtD
Icosapent ethyl—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000657	0.000873	CcSEcCtD
Icosapent ethyl—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000656	0.000872	CcSEcCtD
Icosapent ethyl—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000655	0.000871	CcSEcCtD
Icosapent ethyl—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000655	0.000871	CcSEcCtD
Icosapent ethyl—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000655	0.000871	CcSEcCtD
Icosapent ethyl—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000653	0.000868	CcSEcCtD
Icosapent ethyl—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000653	0.000868	CcSEcCtD
Icosapent ethyl—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000652	0.000866	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000651	0.000866	CcSEcCtD
Icosapent ethyl—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000651	0.000865	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000645	0.000858	CcSEcCtD
Icosapent ethyl—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000645	0.000858	CcSEcCtD
Icosapent ethyl—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000645	0.000858	CcSEcCtD
Icosapent ethyl—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000645	0.000857	CcSEcCtD
Icosapent ethyl—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000645	0.000857	CcSEcCtD
Icosapent ethyl—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000644	0.000855	CcSEcCtD
Icosapent ethyl—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000644	0.000855	CcSEcCtD
Icosapent ethyl—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000643	0.000854	CcSEcCtD
Icosapent ethyl—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000639	0.00085	CcSEcCtD
Icosapent ethyl—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000639	0.00085	CcSEcCtD
Icosapent ethyl—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000639	0.00085	CcSEcCtD
Icosapent ethyl—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000848	CcSEcCtD
Icosapent ethyl—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000636	0.000846	CcSEcCtD
Icosapent ethyl—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000635	0.000845	CcSEcCtD
Icosapent ethyl—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000632	0.00084	CcSEcCtD
Icosapent ethyl—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.00084	CcSEcCtD
Icosapent ethyl—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000631	0.000839	CcSEcCtD
Icosapent ethyl—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00063	0.000837	CcSEcCtD
Icosapent ethyl—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000628	0.000835	CcSEcCtD
Icosapent ethyl—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000628	0.000834	CcSEcCtD
Icosapent ethyl—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.000831	CcSEcCtD
Icosapent ethyl—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000625	0.00083	CcSEcCtD
Icosapent ethyl—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000624	0.00083	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000623	0.000828	CcSEcCtD
Icosapent ethyl—Rash—Stavudine—acquired immunodeficiency syndrome	0.000623	0.000828	CcSEcCtD
Icosapent ethyl—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000622	0.000827	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000622	0.000826	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000621	0.000826	CcSEcCtD
Icosapent ethyl—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000619	0.000822	CcSEcCtD
Icosapent ethyl—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000617	0.000821	CcSEcCtD
Icosapent ethyl—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000617	0.000821	CcSEcCtD
Icosapent ethyl—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000616	0.000819	CcSEcCtD
Icosapent ethyl—Rash—Abacavir—acquired immunodeficiency syndrome	0.000614	0.000816	CcSEcCtD
Icosapent ethyl—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000613	0.000815	CcSEcCtD
Icosapent ethyl—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000613	0.000815	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000613	0.000815	CcSEcCtD
Icosapent ethyl—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.000814	CcSEcCtD
Icosapent ethyl—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000609	0.000809	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000608	0.000808	CcSEcCtD
Icosapent ethyl—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000607	0.000807	CcSEcCtD
Icosapent ethyl—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000604	0.000803	CcSEcCtD
Icosapent ethyl—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000603	0.000802	CcSEcCtD
Icosapent ethyl—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000596	0.000793	CcSEcCtD
Icosapent ethyl—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000595	0.000791	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000595	0.000791	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.000788	CcSEcCtD
Icosapent ethyl—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000588	0.000781	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000585	0.000778	CcSEcCtD
Icosapent ethyl—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000584	0.000777	CcSEcCtD
Icosapent ethyl—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000581	0.000772	CcSEcCtD
Icosapent ethyl—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00058	0.000771	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000576	0.000766	CcSEcCtD
Icosapent ethyl—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000573	0.000762	CcSEcCtD
Icosapent ethyl—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000573	0.000761	CcSEcCtD
Icosapent ethyl—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.000759	CcSEcCtD
Icosapent ethyl—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.000759	CcSEcCtD
Icosapent ethyl—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.000759	CcSEcCtD
Icosapent ethyl—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000568	0.000755	CcSEcCtD
Icosapent ethyl—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000566	0.000752	CcSEcCtD
Icosapent ethyl—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000565	0.000751	CcSEcCtD
Icosapent ethyl—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000559	0.000742	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000558	0.000742	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.000737	CcSEcCtD
Icosapent ethyl—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000554	0.000737	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.000731	CcSEcCtD
Icosapent ethyl—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000549	0.00073	CcSEcCtD
Icosapent ethyl—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000549	0.00073	CcSEcCtD
Icosapent ethyl—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000546	0.000726	CcSEcCtD
Icosapent ethyl—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000546	0.000726	CcSEcCtD
Icosapent ethyl—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000541	0.00072	CcSEcCtD
Icosapent ethyl—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000541	0.00072	CcSEcCtD
Icosapent ethyl—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000541	0.000719	CcSEcCtD
Icosapent ethyl—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00054	0.000717	CcSEcCtD
Icosapent ethyl—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000534	0.00071	CcSEcCtD
Icosapent ethyl—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000533	0.000708	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000529	0.000704	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000529	0.000703	CcSEcCtD
Icosapent ethyl—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000528	0.000702	CcSEcCtD
Icosapent ethyl—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.000701	CcSEcCtD
Icosapent ethyl—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.000697	CcSEcCtD
Icosapent ethyl—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.000697	CcSEcCtD
Icosapent ethyl—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000518	0.000688	CcSEcCtD
Icosapent ethyl—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000511	0.000679	CcSEcCtD
Icosapent ethyl—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.000675	CcSEcCtD
Icosapent ethyl—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000508	0.000675	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000505	0.000671	CcSEcCtD
Icosapent ethyl—Rash—Indinavir—acquired immunodeficiency syndrome	0.000503	0.000669	CcSEcCtD
Icosapent ethyl—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000503	0.000669	CcSEcCtD
Icosapent ethyl—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000499	0.000663	CcSEcCtD
Icosapent ethyl—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.000644	CcSEcCtD
Icosapent ethyl—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00048	0.000638	CcSEcCtD
Icosapent ethyl—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000479	0.000637	CcSEcCtD
Icosapent ethyl—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000477	0.000635	CcSEcCtD
Icosapent ethyl—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000476	0.000632	CcSEcCtD
Icosapent ethyl—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.000632	CcSEcCtD
Icosapent ethyl—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.000628	CcSEcCtD
Icosapent ethyl—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000461	0.000613	CcSEcCtD
Icosapent ethyl—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000459	0.00061	CcSEcCtD
Icosapent ethyl—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.000605	CcSEcCtD
Icosapent ethyl—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.000604	CcSEcCtD
Icosapent ethyl—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000455	0.000604	CcSEcCtD
Icosapent ethyl—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000441	0.000587	CcSEcCtD
Icosapent ethyl—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00044	0.000585	CcSEcCtD
Icosapent ethyl—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.000576	CcSEcCtD
Icosapent ethyl—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.000565	CcSEcCtD
Icosapent ethyl—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000424	0.000564	CcSEcCtD
Icosapent ethyl—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000421	0.000559	CcSEcCtD
Icosapent ethyl—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000421	0.000559	CcSEcCtD
Icosapent ethyl—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000409	0.000543	CcSEcCtD
Icosapent ethyl—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000405	0.000539	CcSEcCtD
Icosapent ethyl—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000538	CcSEcCtD
Icosapent ethyl—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000538	CcSEcCtD
Icosapent ethyl—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00039	0.000518	CcSEcCtD
Icosapent ethyl—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.000514	CcSEcCtD
Icosapent ethyl—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.000513	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000326	0.00615	CbGpPWpGaD
